11-113779919-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001101389.1(CLDN25):c.124G>A(p.Glu42Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001101389.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152040Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000401 AC: 10AN: 249262Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135200
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461572Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727102
GnomAD4 genome AF: 0.000151 AC: 23AN: 152040Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74254
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.124G>A (p.E42K) alteration is located in exon 1 (coding exon 1) of the CLDN25 gene. This alteration results from a G to A substitution at nucleotide position 124, causing the glutamic acid (E) at amino acid position 42 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at